The current GRPH market cap is 185.19M. The company's latest EPS is USD -2.1404 and P/E is -11.50.
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -60.44M | -105.64M | -135.19M |
Net Income | -70.76M | -101.05M | -124.65M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Assets | 401.99M | 321.9M | 188.46M |
Total Liabilities | 17.94M | 25.61M | 4.87M |
Total Equity | 384.05M | 296.29M | 183.58M |
Market Cap | 185.19M |
Price to Earnings Ratio | -11.50 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.78 |
Price to Book Ratio | 7.81 |
Dividend Yield | - |
Shares Outstanding | 58.24M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.02 (0.63%) |
Company Name | Graphite Bio Inc |
Address |
1201 north market st wilmington, delaware 19801 |
Website | https://www.lenz-tx.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions